
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma
Wen‐Kai Weng, Sally Arai, Andrew R. Rezvani, et al.
Blood Advances (2020) Vol. 4, Iss. 18, pp. 4474-4482
Open Access | Times Cited: 38
Wen‐Kai Weng, Sally Arai, Andrew R. Rezvani, et al.
Blood Advances (2020) Vol. 4, Iss. 18, pp. 4474-4482
Open Access | Times Cited: 38
Showing 1-25 of 38 citing articles:
Mycosis Fungoides and Sézary Syndrome
Robert Stuver, Alison J. Moskowitz, Sarah Noor, et al.
(2023), pp. 635-646
Closed Access | Times Cited: 177
Robert Stuver, Alison J. Moskowitz, Sarah Noor, et al.
(2023), pp. 635-646
Closed Access | Times Cited: 177
Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study
Adèle de Masson, M. Beylot‐Barry, C. Ram‐Wolff, et al.
The Lancet (2023) Vol. 401, Iss. 10392, pp. 1941-1950
Open Access | Times Cited: 34
Adèle de Masson, M. Beylot‐Barry, C. Ram‐Wolff, et al.
The Lancet (2023) Vol. 401, Iss. 10392, pp. 1941-1950
Open Access | Times Cited: 34
Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study
Jan P. Nicolay, Susanne Melchers, J. Albrecht, et al.
Blood (2023) Vol. 142, Iss. 9, pp. 794-805
Open Access | Times Cited: 21
Jan P. Nicolay, Susanne Melchers, J. Albrecht, et al.
Blood (2023) Vol. 142, Iss. 9, pp. 794-805
Open Access | Times Cited: 21
International study of treatment efficacy in SS shows superiority of combination therapy and heterogeneity of treatment strategies
Belinda A. Campbell, Gábor Dobos, Zahra Haider, et al.
Blood Advances (2023) Vol. 7, Iss. 21, pp. 6639-6647
Open Access | Times Cited: 16
Belinda A. Campbell, Gábor Dobos, Zahra Haider, et al.
Blood Advances (2023) Vol. 7, Iss. 21, pp. 6639-6647
Open Access | Times Cited: 16
Is It Time to Assess T Cell Clonality by Next-Generation Sequencing in Mature T Cell Lymphoid Neoplasms? A Scoping Review
Rina Kansal
Journal of Molecular Pathology (2025) Vol. 6, Iss. 1, pp. 2-2
Open Access
Rina Kansal
Journal of Molecular Pathology (2025) Vol. 6, Iss. 1, pp. 2-2
Open Access
Haematopoietic stem cell transplant in cutaneous T‐cell lymphomas: A multicentre propensity‐score matched study
Lía Bejarano, Mercè Grau‐Pérez, Marina Paíno‐Román, et al.
Journal of the European Academy of Dermatology and Venereology (2025)
Closed Access
Lía Bejarano, Mercè Grau‐Pérez, Marina Paíno‐Román, et al.
Journal of the European Academy of Dermatology and Venereology (2025)
Closed Access
Allogeneic stem cell transplant for treatment of mycosis fungoides and Sezary syndrome: a systematic review and meta-analysis
Amrita Goyal, Daniel E. O’Leary, Francine M. Foss
Bone Marrow Transplantation (2023) Vol. 59, Iss. 1, pp. 41-51
Closed Access | Times Cited: 12
Amrita Goyal, Daniel E. O’Leary, Francine M. Foss
Bone Marrow Transplantation (2023) Vol. 59, Iss. 1, pp. 41-51
Closed Access | Times Cited: 12
Long term outcomes of nonmyeloablative allogeneic stem cell transplantation with TSEB TLI and ATG for Mycosis Fungoides and Sezary Syndrome
Stephen Morris, B. Thomas, Renuka Palanicawandar, et al.
Bone Marrow Transplantation (2024) Vol. 59, Iss. 6, pp. 874-879
Open Access | Times Cited: 4
Stephen Morris, B. Thomas, Renuka Palanicawandar, et al.
Bone Marrow Transplantation (2024) Vol. 59, Iss. 6, pp. 874-879
Open Access | Times Cited: 4
Allogeneic hematopoietic stem cell transplantation after mogamulizumab in T-cell lymphoma patients: a retrospective analysis
Mary Jo Lechowicz, Christina H. Smith, Robert Ristuccia, et al.
International Journal of Hematology (2024) Vol. 119, Iss. 6, pp. 736-744
Open Access | Times Cited: 4
Mary Jo Lechowicz, Christina H. Smith, Robert Ristuccia, et al.
International Journal of Hematology (2024) Vol. 119, Iss. 6, pp. 736-744
Open Access | Times Cited: 4
Breaking Down the Barriers for Patients With Cutaneous T-Cell Lymphoma: Current Controversies and Challenges for Radiation Oncologists in 2024
Belinda A. Campbell, H. Miles Prince, Karin Thursky, et al.
Seminars in Radiation Oncology (2024) Vol. 35, Iss. 1, pp. 110-125
Open Access | Times Cited: 3
Belinda A. Campbell, H. Miles Prince, Karin Thursky, et al.
Seminars in Radiation Oncology (2024) Vol. 35, Iss. 1, pp. 110-125
Open Access | Times Cited: 3
Integrating novel agents into the treatment of advanced mycosis fungoides and Sézary syndrome
Michael S. Khodadoust, Eric Mou, Youn H. Kim
Blood (2022) Vol. 141, Iss. 7, pp. 695-703
Open Access | Times Cited: 11
Michael S. Khodadoust, Eric Mou, Youn H. Kim
Blood (2022) Vol. 141, Iss. 7, pp. 695-703
Open Access | Times Cited: 11
Mycosis Fungoides and Sézary Syndrome
Walter Hanel, Catherine Chung, John Reneau
Holland‐Frei Cancer Medicine (2022), pp. 1-7
Closed Access | Times Cited: 10
Walter Hanel, Catherine Chung, John Reneau
Holland‐Frei Cancer Medicine (2022), pp. 1-7
Closed Access | Times Cited: 10
Allogeneic Hematopoietic Stem Cell Transplantation in Cutaneous T-Cell Lymphomas
Maëlle Dumont, Régis Peffault de Latour, C. Ram‐Wolff, et al.
Cancers (2020) Vol. 12, Iss. 10, pp. 2856-2856
Open Access | Times Cited: 15
Maëlle Dumont, Régis Peffault de Latour, C. Ram‐Wolff, et al.
Cancers (2020) Vol. 12, Iss. 10, pp. 2856-2856
Open Access | Times Cited: 15
What factors guide treatment selection in mycosis fungoides and Sezary syndrome?
Youn H. Kim
Hematology (2021) Vol. 2021, Iss. 1, pp. 303-312
Open Access | Times Cited: 11
Youn H. Kim
Hematology (2021) Vol. 2021, Iss. 1, pp. 303-312
Open Access | Times Cited: 11
Are we there yet? cellular therapies for cutaneous T cell lymphoma
Pınar Ataca Atilla, Erden Atilla
Current Research in Translational Medicine (2023) Vol. 71, Iss. 2, pp. 103390-103390
Closed Access | Times Cited: 4
Pınar Ataca Atilla, Erden Atilla
Current Research in Translational Medicine (2023) Vol. 71, Iss. 2, pp. 103390-103390
Closed Access | Times Cited: 4
Allogeneic transplantation and cellular therapies in cutaneous T-cell lymphoma
Amrita Goyal, Francine M. Foss
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 1-2, pp. 41-58
Closed Access | Times Cited: 1
Amrita Goyal, Francine M. Foss
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 1-2, pp. 41-58
Closed Access | Times Cited: 1
Long-term remission with allogeneic transplant in patients with refractory/relapsed cutaneous cytotoxic T-cell lymphoma
Wen‐Kai Weng, Chaitanya Iragavarapu, G Weng, et al.
Deleted Journal (2024) Vol. 1, Iss. 2, pp. 100007-100007
Open Access | Times Cited: 1
Wen‐Kai Weng, Chaitanya Iragavarapu, G Weng, et al.
Deleted Journal (2024) Vol. 1, Iss. 2, pp. 100007-100007
Open Access | Times Cited: 1
The role of stem cell transplant (auto and allo) in PTCL and CTCL
Peter Dreger, Norbert Schmitz
Hematology (2024) Vol. 2024, Iss. 1, pp. 69-77
Closed Access | Times Cited: 1
Peter Dreger, Norbert Schmitz
Hematology (2024) Vol. 2024, Iss. 1, pp. 69-77
Closed Access | Times Cited: 1
Long-term outcomes for allogeneic bone marrow transplantation in Sezary syndrome and mycosis fungoides
Jessica Elliott, Shalini Ahlawat, H. Miles Prince, et al.
Bone Marrow Transplantation (2022) Vol. 57, Iss. 11, pp. 1724-1726
Closed Access | Times Cited: 5
Jessica Elliott, Shalini Ahlawat, H. Miles Prince, et al.
Bone Marrow Transplantation (2022) Vol. 57, Iss. 11, pp. 1724-1726
Closed Access | Times Cited: 5
Minimal/Measurable Residual Disease Monitoring in Patients with Lymphoid Neoplasms by High-Throughput Sequencing of the T-Cell Receptor
Jack K. Tung, Diwash Jangam, Chandler Ho, et al.
Journal of Molecular Diagnostics (2023) Vol. 25, Iss. 6, pp. 331-341
Closed Access | Times Cited: 2
Jack K. Tung, Diwash Jangam, Chandler Ho, et al.
Journal of Molecular Diagnostics (2023) Vol. 25, Iss. 6, pp. 331-341
Closed Access | Times Cited: 2
Allogeneic Stem Cell Transplantation with a Novel Reduced Intensity Conditioning Regimen for the Treatment of Patients with Primary Cutaneous T-cell Lymphomas
Maria Stamouli, Konstantinos Gkirkas, Aggeliki Karagiannidi, et al.
Clinical Hematology International (2021) Vol. 3, Iss. 2, pp. 72-72
Open Access | Times Cited: 4
Maria Stamouli, Konstantinos Gkirkas, Aggeliki Karagiannidi, et al.
Clinical Hematology International (2021) Vol. 3, Iss. 2, pp. 72-72
Open Access | Times Cited: 4
On the way to curing advanced-stage mycosis fungoides/ Sézary syndrome
Seda Pürnak, Chitra Hosing, Bouthaina S. Dabaja, et al.
Clinical Lymphoma Myeloma & Leukemia (2024) Vol. 24, Iss. 12, pp. 827-836
Closed Access
Seda Pürnak, Chitra Hosing, Bouthaina S. Dabaja, et al.
Clinical Lymphoma Myeloma & Leukemia (2024) Vol. 24, Iss. 12, pp. 827-836
Closed Access
Minimal residual disease detection in lymphoma: methods, procedures and clinical significance
Sijun Zhang, Xiangyu Wang, Zhen-Zhen Yang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Sijun Zhang, Xiangyu Wang, Zhen-Zhen Yang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access